30 results
424B3
sd6lw5ev ob0oo
4 Apr 23
Prospectus supplement
4:57pm
POS AM
kzl49kpg
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
8-K
EX-99.1
7kz25kvcgf4
17 Nov 22
Inhibikase Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Period Activity
4:30pm
PRE 14A
qpjx 3bkccgk
21 Apr 22
Preliminary proxy
4:33pm
S-3
epclapet
7 Feb 22
Shelf registration
12:00am
424B4
zgj87gxi pstmjwu1ud
17 Jun 21
Prospectus supplement with pricing info
4:31pm
DRS
kmuq35oyq8qmnyef
2 Jun 21
Draft registration statement
12:00am
DEFA14A
sb0y6xc1pdrlaw4x4
30 Apr 21
Additional proxy soliciting materials
5:21pm